Grant Details
Grant Number: |
2R01CA090902-05A2 Interpret this number |
Primary Investigator: |
Hsieh, Chung-Cheng |
Organization: |
Univ Of Massachusetts Med Sch Worcester |
Project Title: |
Stem Cells and Perinatal Factors for Breast Cancer Risk |
Fiscal Year: |
2008 |
Abstract
DESCRIPTION (provided by applicant): The goal of CA90902 is to examine in umbilical cord blood samples the relation between measurements of stem cell potential and perinatal factors for breast cancer risk. The study is based on the hypothesis that cancer risk can be influenced in part by the hormonal environment in utero and that cancer risk is proportional to the number of primitive proliferating stem cells. In the previous grant cycle, we focused on the correlations between standard hematopoietic stem cell measurements and major endogenous hormones as well as birth weight. Building on the emerging results, we propose in this continuation application to explore further the relation between stem cell measurements and additional perinatal characteristics (preeclampsia, twin membership, and preterm birth) and endogenous hormones and growth factors (IGF-2) that have been found to be associated with breast cancer risk in adult life in epidemiologic studies or that might be relevant in prenatal origin hypothesis on breast cancer risk. Stem cell and growth factor measurements expand to include endothelial progenitor cells and angiogenic factors that might be related to intrauterine growth retardation. Umbilical cord blood from 240 donors with a wide range of maternal, gestational, and neonatal characteristics will be included. Stem cells include CD34+, CD34+/CD38-, CD34+/CD133+/VEGFR-2+ subpopulations, as well as colony-forming cells will be measured. Pro- and anti-angiogenic factors will be measured to assess angiogenic potential and to correlate with levels of endothelial progenitor cells and other study variables. We will apply regression analysis treating as outcome variables each measurement of stem cell potential and as predictor variables perinatal characteristics, hormones, and angiogenic factors. A third aim will examine whether patients diagnosed with breast cancer (n=80) have higher measurements of stem cell potential than control subjects without breast cancer (n=80). It will also explore whether levels of hematopoietic stem cells in the breast cancer patients are correlated with CD44+/CD24- cells, a putative breast cancer stem cell, in their tumor tissue samples. The proposed study could contribute information on whether hormonal carcinogenesis process starts already early in the perinatal period and whether stem cell potential may be a common denominator for the effect of perinatal factors, providing a closer link between in utero exposure and risk of breast and other cancers. More speculatively, examining perinatal factors that include endogenous hormones and maternal, gestational, and neonatal characteristics might also potentially lead to future applications for early identification of high-risk individuals, perhaps through stem cell measurement, for potential cancer prevention measures. PUBLIC HEALTH RELEVANCE: Epidemiologic studies have provided evidence that in utero and perinatal events or conditions impact risk of breast and perhaps other cancers in the offspring. It has been difficult to directly study the pathogenic mechanisms involved in the sequences of events between early life exposures and adult life outcome. The proposed study could contribute information on whether the hormonal-influenced carcinogenesis process starts early in the perinatal period and whether stem cell potential may be viewed as a non-genetic indicator of host susceptibility, summarizing the effects of perinatal factors, and providing a closer link between in utero exposure and breast cancer risk. Examining perinatal risk factors that include endogenous hormones and maternal, gestational, and newborn characteristics might also potentially lead to future applications for early identification of high-risk individuals, through measurement of stem cell potential as a susceptibility marker summarizing the effect of a multitude of factors, for potential cancer surveillance and prevention measures.
Publications
Prenatal Maternal Physical Activity And Stem Cells In Umbilical Cord Blood
Authors: Onoyama S.
, Qiu L.I.
, Low H.P.
, Chang C.I.
, Strohsnitter W.C.
, Norwitz E.R.
, Lopresti M.
, Edmiston K.
, Lee I.M.
, Trichopoulos D.
, et al.
.
Source: Medicine And Science In Sports And Exercise, 2016 Jan; 48(1), p. 82-9.
PMID: 26197028
Related Citations
Effect Of Preeclampsia On Umbilical Cord Blood Stem Cells In Relation To Breast Cancer Susceptibility In The Offspring
Authors: Qiu L.
, Onoyama S.
, Low H.P.
, Chang C.I.
, Strohsnitter W.C.
, Norwitz E.R.
, Lopresti M.
, Edmiston K.
, Lambe M.
, Trichopoulos D.
, et al.
.
Source: Carcinogenesis, 2015 Jan; 36(1), p. 94-8.
PMID: 25398884
Related Citations
Screening Preeclamptic Cord Plasma For Proteins Associated With Decreased Breast Cancer Susceptibility
Authors: Low H.P.
, Tiwari A.
, Janjanam J.
, Qiu L.
, Chang C.I.
, Strohsnitter W.C.
, Norwitz E.R.
, Tam S.W.
, Evans J.E.
, Green K.M.
, et al.
.
Source: Genomics, Proteomics & Bioinformatics, 2013 Dec; 11(6), p. 335-44.
PMID: 24296084
Related Citations
Novel Measurements Of Mammary Stem Cells In Human Umbilical Cord Blood As Prospective Predictors Of Breast Cancer Susceptibility In Later Life
Authors: Qiu L.
, Low H.P.
, Chang C.I.
, Strohsnitter W.C.
, Anderson M.
, Edmiston K.
, Adami H.O.
, Ekbom A.
, Hall P.
, Lagiou P.
, et al.
.
Source: Annals Of Oncology : Official Journal Of The European Society For Medical Oncology / Esmo, 2012 Jan; 23(1), p. 245-50.
PMID: 21515664
Related Citations
Prenatal Modulation Of Breast Density And Breast Stem Cells By Insulin-like Growth Factor-1
Authors: Chang C.I.
, Low H.P.
, Qiu L.
, Strohsnitter W.C.
, Hsieh C.C.
.
Source: American Journal Of Stem Cells, 2012; 1(3), p. 239-52.
PMID: 23671811
Related Citations
Correlation of umbilical cord blood haematopoietic stem and progenitor cell levels with birth weight: implications for a prenatal influence on cancer risk.
Authors: Strohsnitter W.C.
, Savarese T.M.
, Low H.P.
, Chelmow D.P.
, Lagiou P.
, Lambe M.
, Edmiston K.
, Liu Q.
, Baik I.
, Noller K.L.
, et al.
.
Source: British Journal Of Cancer, 2008-02-12 00:00:00.0; 98(3), p. 660-3.
EPub date: 2008-02-12 00:00:00.0.
PMID: 18256588
Related Citations
Correlation Of Umbilical Cord Blood Hormones And Growth Factors With Stem Cell Potential: Implications For The Prenatal Origin Of Breast Cancer Hypothesis
Authors: Savarese T.M.
, Strohsnitter W.C.
, Low H.P.
, Liu Q.
, Baik I.
, Okulicz W.
, Chelmow D.P.
, Lagiou P.
, Quesenberry P.J.
, Noller K.L.
, et al.
.
Source: Breast Cancer Research : Bcr, 2007; 9(3), p. R29.
PMID: 17501995
Related Citations
Reproducibility Of Assays For Steroid Hormones, Prolactin And Insulin-like Growth Factor-1 In Umbilical Cord Blood
Authors: Baik I.
, Liu Q.
, Sturgeon S.
, Stanek E.J.
, Okulicz W.
, Hsieh C.C.
.
Source: Paediatric And Perinatal Epidemiology, 2006 Jan; 20(1), p. 79-86.
PMID: 16420345
Related Citations
Normal Breast Stem Cells, Malignant Breast Stem Cells, And The Perinatal Origin Of Breast Cancer
Authors: Savarese T.M.
, Low H.P.
, Baik I.
, Strohsnitter W.C.
, Hsieh C.C.
.
Source: Stem Cell Reviews, 2006; 2(2), p. 103-10.
PMID: 17237548
Related Citations
Association Of Fetal Hormone Levels With Stem Cell Potential: Evidence For Early Life Roots Of Human Cancer
Authors: Baik I.
, Devito W.J.
, Ballen K.
, Becker P.S.
, Okulicz W.
, Liu Q.
, Delpapa E.
, Lagiou P.
, Sturgeon S.
, Trichopoulos D.
, et al.
.
Source: Cancer Research, 2005-01-01 00:00:00.0; 65(1), p. 358-63.
PMID: 15665314
Related Citations
Stem Cells And Prenatal Origin Of Breast Cancer
Authors: Baik I.
, Becker P.S.
, DeVito W.J.
, Lagiou P.
, Ballen K.
, Quesenberry P.J.
, Hsieh C.C.
.
Source: Cancer Causes & Control : Ccc, 2004 Jun; 15(5), p. 517-30.
PMID: 15286472
Related Citations